Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

RIP140 in monocytes/macrophages regulates osteoclast differentiation and bone homeostasis.

Lee B, Iwaniec UT, Turner RT, Lin YW, Clarke BL, Gingery A, Wei LN.

JCI Insight. 2017 Apr 6;2(7):e90517. doi: 10.1172/jci.insight.90517.

2.

Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis.

Lin SJ, Ho HC, Lee YF, Liu NC, Liu S, Li G, Shyr CR, Chang C.

Reprod Biol Endocrinol. 2012 Jun 7;10:43.

3.

Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Mukherjee A, Rotwein P.

Mol Cell Biol. 2012 Jan;32(2):490-500. doi: 10.1128/MCB.06361-11. Epub 2011 Nov 7.

4.

MHC class II transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity.

Benasciutti E, Mariani E, Oliva L, Scolari M, Perilli E, Barras E, Milan E, Orfanelli U, Fazzalari NL, Campana L, Capobianco A, Otten L, Particelli F, Acha-Orbea H, Baruffaldi F, Faccio R, Sitia R, Reith W, Cenci S.

J Bone Miner Res. 2014 Feb;29(2):290-303. doi: 10.1002/jbmr.2090.

5.

Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis.

Ishii M, Egen JG, Klauschen F, Meier-Schellersheim M, Saeki Y, Vacher J, Proia RL, Germain RN.

Nature. 2009 Mar 26;458(7237):524-8. doi: 10.1038/nature07713. Epub 2009 Feb 8. Erratum in: Nature. 2010 Jun 17;465(7300):966.

6.

Water extract of Spatholobus suberectus inhibits osteoclast differentiation and bone resorption.

Ha H, Shim KS, An H, Kim T, Ma JY.

BMC Complement Altern Med. 2013 May 21;13:112. doi: 10.1186/1472-6882-13-112.

7.

Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.

Koskinen C, Persson E, Baldock P, Stenberg Å, Boström I, Matozaki T, Oldenborg PA, Lundberg P.

J Biol Chem. 2013 Oct 11;288(41):29333-44. doi: 10.1074/jbc.M113.494591. Epub 2013 Aug 29.

8.

Streptococcus gordonii induces bone resorption by increasing osteoclast differentiation and reducing osteoblast differentiation.

Park OJ, Kim J, Kim HY, Kwon Y, Yun CH, Han SH.

Microb Pathog. 2019 Jan;126:218-223. doi: 10.1016/j.micpath.2018.11.005. Epub 2018 Nov 7.

PMID:
30414445
9.

M-CSF priming of osteoclast precursors can cause osteoclastogenesis-insensitivity, which can be prevented and overcome on bone.

De Vries TJ, Schoenmaker T, Aerts D, Grevers LC, Souza PP, Nazmi K, van de Wiel M, Ylstra B, Lent PL, Leenen PJ, Everts V.

J Cell Physiol. 2015 Jan;230(1):210-25. doi: 10.1002/jcp.24702.

PMID:
24962140
10.

Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.

Kogawa M, Findlay DM, Anderson PH, Ormsby R, Vincent C, Morris HA, Atkins GJ.

Endocrinology. 2010 Oct;151(10):4613-25. doi: 10.1210/en.2010-0334. Epub 2010 Aug 25.

PMID:
20739402
11.

Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.

Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.

J Bone Miner Res. 2005 Sep;20(9):1659-68. Epub 2005 May 2.

12.

Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts.

Kim JH, Youn BU, Kim K, Moon JB, Lee J, Nam KI, Park YW, O'Leary DD, Kim KK, Kim N.

Cell Death Differ. 2014 Oct;21(10):1613-21. doi: 10.1038/cdd.2014.71. Epub 2014 Jun 6.

13.

Inactivation of Regulatory-associated Protein of mTOR (Raptor)/Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.

Dai Q, Xie F, Han Y, Ma X, Zhou S, Jiang L, Zou W, Wang J.

J Biol Chem. 2017 Jan 6;292(1):196-204. doi: 10.1074/jbc.M116.764761. Epub 2016 Nov 22.

14.

v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation.

Lee SH, Rho J, Jeong D, Sul JY, Kim T, Kim N, Kang JS, Miyamoto T, Suda T, Lee SK, Pignolo RJ, Koczon-Jaremko B, Lorenzo J, Choi Y.

Nat Med. 2006 Dec;12(12):1403-9. Epub 2006 Nov 26.

PMID:
17128270
15.

Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.

Kim HJ, Ohk B, Yoon HJ, Kang WY, Seong SJ, Kim SY, Yoon YR.

Cell Signal. 2017 Jan;29:226-232. doi: 10.1016/j.cellsig.2016.11.007. Epub 2016 Nov 9.

PMID:
27836739
16.

Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.

Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K.

J Cell Physiol. 2004 Oct;201(1):17-25.

PMID:
15281085
17.

Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.

Michael H, Härkönen PL, Väänänen HK, Hentunen TA.

J Bone Miner Res. 2005 Dec;20(12):2224-32. Epub 2005 Aug 1.

18.

Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.

Kim JY, Cheon YH, Kwak SC, Baek JM, Yoon KH, Lee MS, Oh J.

J Bone Miner Res. 2014 Jul;29(7):1541-53. doi: 10.1002/jbmr.2183.

19.

Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor.

Huber DM, Bendixen AC, Pathrose P, Srivastava S, Dienger KM, Shevde NK, Pike JW.

Endocrinology. 2001 Sep;142(9):3800-8.

PMID:
11517156
20.

Necrostatin-7 suppresses RANK-NFATc1 signaling and attenuates macrophage to osteoclast differentiation.

Fuji H, Ohmae S, Noma N, Takeiri M, Yasutomi H, Izumi K, Ito M, Toyomoto M, Iwaki S, Takemoto K, Seo S, Taura K, Hida S, Aoyama M, Ishihama Y, Hagiwara M, Takeda N, Hatano E, Iwaisako K, Uemoto S, Asagiri M.

Biochem Biophys Res Commun. 2018 Sep 5;503(2):544-549. doi: 10.1016/j.bbrc.2018.05.153. Epub 2018 Jul 7.

PMID:
29800570

Supplemental Content

Support Center